crenezumab (RG7412) / AC Immune 
Welcome,         Profile    Billing    Logout  
 9 Diseases   1 Trial   1 Trial   304 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
crenezumab (RG7412) / AC Immune
API ADAD Colombia , NCT01998841: A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort

Completed
2
252
RoW
Crenezumab, MABT5102A, Placebo
Genentech, Inc., Banner Alzheimer's Institute, National Institute on Aging (NIA)
Alzheimer's Disease
03/22
08/23

Download Options